loading
Applied Therapeutics Inc stock is traded at $0.3692, with a volume of 1.19M. It is up +1.48% in the last 24 hours and down -9.27% over the past month. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.3638
Open:
$0.3701
24h Volume:
1.19M
Relative Volume:
0.55
Market Cap:
$50.02M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
-0.2735
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
+4.50%
1M Performance:
-9.27%
6M Performance:
-71.16%
1Y Performance:
-91.80%
1-Day Range:
Value
$0.365
$0.389
1-Week Range:
Value
$0.345
$0.389
52-Week Range:
Value
$0.295
$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
Name
Applied Therapeutics Inc
Name
Phone
212-220-9226
Name
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
Employee
36
Name
Twitter
@Applied_Tx
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
APLT's Discussions on Twitter

Compare APLT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
APLT
Applied Therapeutics Inc
0.3692 50.02M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-23-24 Downgrade William Blair Outperform → Mkt Perform
Dec-02-24 Downgrade UBS Buy → Neutral
Nov-29-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jul-31-24 Initiated William Blair Outperform
Mar-26-24 Initiated RBC Capital Mkts Outperform
Feb-22-24 Initiated Leerink Partners Outperform
Jan-04-22 Downgrade Barclays Overweight → Equal Weight
Aug-27-21 Downgrade Goldman Neutral → Sell
Jun-25-21 Resumed Goldman Neutral
Oct-08-20 Initiated Truist Buy
Apr-22-20 Initiated Goldman Buy
Feb-27-20 Initiated Barclays Overweight
Jun-10-19 Initiated Citigroup Buy
Jun-10-19 Initiated Cowen Outperform
Jun-10-19 Initiated Robert W. Baird Outperform
View All

Applied Therapeutics Inc Stock (APLT) Latest News

pulisher
Jun 06, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Grows Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT - ACCESS Newswire

Jun 03, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Grows Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 31, 2025
pulisher
May 31, 2025

Janus Henderson Group PLC Sells 10,505,737 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 31, 2025
pulisher
May 27, 2025

Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud - The Intercept

May 27, 2025
pulisher
May 27, 2025

Applied Therapeutics (NASDAQ:APLT) Rating Increased to Sell at Wall Street Zen - MarketBeat

May 27, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Decreases Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 26, 2025
pulisher
May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

Price T Rowe Associates Inc. MD Sells 986,108 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 25, 2025
pulisher
May 24, 2025

William Blair Brokers Increase Earnings Estimates for APLT - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Applied Therapeutics (NASDAQ:APLT) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025
pulisher
May 23, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 23, 2025
pulisher
May 23, 2025

Applied Therapeutics Inc (APLT): An Important Analyst Insights - Stocksregister

May 23, 2025
pulisher
May 22, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

May 22, 2025
pulisher
May 21, 2025

Vestal Point Capital LP Acquires 10,355,000 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 21, 2025
pulisher
May 19, 2025

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN

May 19, 2025
pulisher
May 19, 2025

Applied Therapeutics’ Rare Disease Treatment Flunks in Late-Stage Trial - NewsBreak: Local News & Alerts

May 19, 2025
pulisher
May 19, 2025

New top-line data from Phase II/III trial of govorestat in CMT-SORD - The Pharma Letter

May 19, 2025
pulisher
May 19, 2025

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug By Stocktwits - Investing.com India

May 19, 2025
pulisher
May 19, 2025

Applied Therapeutics Presents Full 12-Month Clinical Results and - GuruFocus

May 19, 2025
pulisher
May 18, 2025

APLT Shares Results from INSPIRE Trial on Govorestat at Peripher - GuruFocus

May 18, 2025
pulisher
May 18, 2025

APLT Shares Results from INSPIRE Trial on Govorestat at Peripheral Nerve Society Meeting | APLT Stock News - GuruFocus

May 18, 2025
pulisher
May 18, 2025

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - The Manila Times

May 18, 2025
pulisher
May 18, 2025

Applied Therapeutics Presents Full 12-Month Clinical - GlobeNewswire

May 18, 2025
pulisher
May 18, 2025

Breakthrough in CMT Treatment: New Clinical Data Shows First-Ever Disease Progression Slowing in 24-Month Study - Stock Titan

May 18, 2025
pulisher
May 18, 2025

Here's Why Amazon Is a Brilliant Buy Now (Hint: It's Not E-Commerce) - The Globe and Mail

May 18, 2025
pulisher
May 18, 2025

Massive News for Apple Stock Investors! - The Globe and Mail

May 18, 2025
pulisher
May 17, 2025

Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) PT at $6.10 - Defense World

May 17, 2025
pulisher
May 17, 2025

Applied Therapeutics’ (APLT) “Sector Perform” Rating Reiterated at Royal Bank of Canada - Defense World

May 17, 2025
pulisher
May 14, 2025

APLT: RBC Capital Reiterates Sector Perform Rating, Price Target Maintained | APLT Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

APLT Reports Financial Position and Advances in Govorestat Resea - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results | APLT Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Applied Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Barclays PLC Sells 27,997 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 14, 2025
pulisher
May 13, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

May 13, 2025
pulisher
May 12, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 12, 2025
pulisher
May 12, 2025

Alyeska Investment Group L.P. Boosts Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 12, 2025
pulisher
May 12, 2025

Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT - ACCESS Newswire

May 12, 2025
pulisher
May 12, 2025

Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire

May 12, 2025

Applied Therapeutics Inc Stock (APLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Cap:     |  Volume (24h):